Economist
Matthieu said:medecines' cost is fixed by the government through negociations with laboratories. It's a deal, we buy hundred of thousands of your medicaments but you make us a good price. It's a fair deal since laboratories still make huge benefits from the social wealthare yet they would make more if they didn't have such constrait, the return being mostly (it's not totaly) free healthcare.
Well, it may be more complicated than this. If the government gets a better price, this maybe due to the fact that the government would be a monopsony (a single buyer) in this case. Just to let you know, a monopsony acts much like a monopoly because they have a large degree of market power. In other words, the government may "underpay" for such medication. Now, I'm not asking you guys to feel sorry for pharmaceutical companies for being underpaid. But I am asking you to think about the unintended consequences of such policy, as it would likely decrease innovation in the medical field. My understanding is that the US produces a very disproportionate percentage of new medication in the world. This may be due to other countries restrictive policies in the medical field (such as intellectual property laws). Luckily for many other countries, they are allowed to "piggyback" of the US discoveries because they can then purchase medication from US pharmaceutical companies. Sometimes I wonder how good medical care would be if all developed countries innovated as much as the US?